Lipoic acid in animal models and clinical use in diabetic retinopathy

Bibliography

• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53
   Google Scholar
• World Health Organization. The prevention of diabetes and its complications. WHO report. 2006. Available from: http:/www.who.int/diabetes/preventionflyer/en/ [Accessed on 7 August 2010]
   Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(S.1):64-71
   Google Scholar
• Tavakoli M, Malik RA. Management of painful diabetic neuropathy. Expert Opin Pharmacother 2008;9:2969-78
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603
   PubMedGoogle Scholar
• Goh SY, Cooper ME. The role of advanced glycation endproducts in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-52
   PubMed Web of Science ®Google Scholar
• Machlin L, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987;1:441-5
   PubMed Web of Science ®Google Scholar
• Nebbioso M, Federici M, Rusciano D, et al. Oxidative stress in preretinopathic diabetes subjects and antioxidants. Diabetes Technol Ther 2012;14:257-63
   Google Scholar
• Lopes de Jesus CC, Atallah AN, Valente O, Moça Trevisani VF. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy. Cochrane Database Syst Rev 2008;1):CD006695
   Google Scholar
• Toshihiko O, Yoji K. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann NY Acad Sci 2006;1043:440-51
   Google Scholar
• Packer L, Witt E, Tritschler H. Alpha-lipoic as a biological antioxidant. Free Radic Biol Med 1995;19:227-50
   PubMed Web of Science ®Google Scholar
• Chidlow G, Schmidt K.-G, Wood J, et al. Alpha-lipoic acid protects the retina against ischaemic–reperfusion. Neuropharmacology 2002;43:1015-25
   PubMed Web of Science ®Google Scholar
• Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthal Physiol 2008;28:503-23
   PubMed Web of Science ®Google Scholar
• Nebbioso M, Scarsella G, Tafani M, Pescosolido N. Mechanisms of ocular neuroprotection by antioxidant molecules in animal models. J Biol Regul Homeost Agents 2013;27:197-209
   PubMed Web of Science ®Google Scholar
• Biewenga G, Haenen G, Bast A. The pharmacology of the antioxidant alpha-lipoic acid. Gen Pharmacol 1997;29:315-31
   PubMedGoogle Scholar
• Johnsen-Soriano S, Garcia-Pous M, Arnal E, et al. Early lipoic acid intake protects retina of diabetic mice. Free Radic Res 2008;42:613-317
   PubMed Web of Science ®Google Scholar
• Borenshtein D, Ofri R, Werman M, et al. Cataract development in diabetic sand rats treated with alpha-lipoic acid and its gamma-linolenic acid conjugate. Diabetes Metab Res Rev 2001;17:44-50
   PubMedGoogle Scholar
• Jacob S, Ruus P, Hermann R, et al. Oral adminstration of RAC-alpha-lipic acid modulates insulin senstivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 1999;27:309-14
   PubMed Web of Science ®Google Scholar
• Santos JM, Kowluru RA. Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid. Invest Ophthalmol Vis Sci 2011;52:8791-8
   PubMedGoogle Scholar
• Salvadó L, Serrano-Marco L, Barroso E, et al. Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus. Expert Opin Ther Targets 2012;16:209-23
   PubMed Web of Science ®Google Scholar
• Dene BA, Maritim AC, Sanders RA, Watkins JB. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocul Pharmacol Ther 2005;21:28-35
   PubMedGoogle Scholar
• Roberts R, Luan H, Berkowitz BA. Lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006;47:4077-82
   Google Scholar
• Jacob S, Rett K, Henriksen EJ, Häring HU. Thiotic acid – effects on insulin sensitivity and glucose-metaboliism. BioFactors 1999;10:169-74
   PubMedGoogle Scholar
• Abiko T, Abiko A, Clermont AC, et al. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 2003;52:829-37
   PubMed Web of Science ®Google Scholar
• Berkowitz BA, Roberts R, Stemmler A, et al. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic acid. Invest Ophthalmol Vis Sci 2007;48:4753-8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odenbach S, Effect of long-term administration of lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004;53:3233-8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2006;47:1594-9
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 2005;7:1581-7
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 2005;76:1051-60
   Google Scholar
• Artwohl M, Muth K, Kosulin K, et al. R-(+)-alpha-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1. Am J Physiol Endocrinol Metab 2007;293:681-9
   Google Scholar
• Lin J, Bierhaus A, Bugert P, et al. Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy. Diabetologia 2006;49:1089-96
   PubMed Web of Science ®Google Scholar
• Lee SG, Lee CG, Yun IH, et al. Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina. Clin Experiment Ophthalmol 2012;40:47-57
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Minchenko AG, Marinescu V, et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001;44:1102-10
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Stevens MJ, Lang HJ. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 2001;62:172-80
   Google Scholar
• Wu H, Xu G, Liao Y, et al. Supplementation with antioxidants attenuates transient worsening of retinopathy in diabetes caused by acute intensive insulin therapy. Graefes Arch Clin Exp Ophthalmol 2012;250:1453-8
   Google Scholar
• Kola B, Boscaro M, Rutter GA, et al. Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 2006;17:205-15
   PubMed Web of Science ®Google Scholar
• Phipps JA, Fletcher EA, Vingrys AJ. Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 2004;45:4592-600
   PubMed Web of Science ®Google Scholar
• Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004;45:1002-8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004;53:3233-8
   PubMed Web of Science ®Google Scholar
• Haritoglou C, Gerss J, Hammes HP, et al. Alpha-lipoic acid for the prevention of diabetic macular edema. Ophthalmologica 2011;226:127-37
   Google Scholar
• Stitt A, Gardiner TA, Alderson NL, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002;51:2826-32
   PubMed Web of Science ®Google Scholar
• Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic acid. Front Pharmacol 2011;2(69):1-15
   Google Scholar
• Ametov A, Barinov A, O'Brien P, et al. The Sensory Symptoms of Diabetic Polyneuropathy are improved witha-lipoic acid: The Sydney Trial. Diabetes Care 2003;3:770-6
   Google Scholar
• Ziegler D, Ametov A, Barinov A, et al. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 2006;29:2365-70
   PubMed Web of Science ®Google Scholar
• Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant a-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995;38:1425-33
   PubMed Web of Science ®Google Scholar
• Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol 2004;3:173-89
   PubMedGoogle Scholar
• Bresciani E, Bussi A, Bazzigaluppi E, Balestrieri G. Insulin autoimmune syndrome induced by α–lipoic acid in a caucasian woman: case report. Diabetes Care 2011;34(9):e146
   Google Scholar
• Lupsa BC, Chong AY, Cochran EK, et al. Autoimmune forms of hypoglycemia. Medicine (Baltimore) 2009;88:141-53
   PubMed Web of Science ®Google Scholar
• Ishida Y, Ohara T, Okuno Y, et al. α-Lipoic acid and insulin autoimmune syndrome. Diabetes Care 2007;30:2240-1
   Google Scholar
• Uchigata Y, Hirata Y, Omori Y, et al. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol 2000;61:154-7
   PubMed Web of Science ®Google Scholar
• Al-Rasheed NM, Al-Rasheed NM, Attia HA, et al. Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms? J Physiol Biochem 2013; Epub ahead of print
   Google Scholar
• Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (a-lipoic acid). A two-year multicenter randomized double blind placebo controlled trial (ALADIN II). Free Rad Res 1999;31:171-9
   PubMed Web of Science ®Google Scholar
• Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the antioxidant a-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care 1997;20:369-73
   PubMed Web of Science ®Google Scholar